Abstract::
Thiazolo- and thiadiazolo-[3,2-a][1,3]diazepines and their patented derivatives, tested with diverse CNS
pharmacological activities, constitute an important class of compounds for new drug development. Therefore, research
efforts were continued to design, synthesize, and evaluate compounds for their ultra-short, short-acting hypnotic,
anticonvulsant, and neuromuscular blocking activities. The present review provides a summary of the work accomplished
by these heterocycles and their biological evaluation.
